ArticleInternational journal of surgery (London, England)2026
Mapping adverse events and monitoring priorities for trastuzumab deruxtecan use in metastatic breast cancer.
Yilong Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.